Cytodyn Inc (CYDY)

[fred198484]

I hope the glass half full case is the right one. It certainly could be. And, even if the glass half empty case is the correct one, they still have the possibility of pulling the proverbial rabbit out of the hat. But the company's track record is pretty dismal so it is hard to give much credence to the glass half full approach. I thought they really were turning things around when they came out with the warrant conversion deal as this made so much sense if good news was near. But then, we didn't get good news, which makes me question whether they were surprised by the interim PE results. Then to give no update on the number of patients recruited is disturbing and to also leave us hanging on when the combo is likely to be completed - well that is not a good sign at all. Nothing is preventing them from offering info on the number of patients currently in the trial or when they think it will finish. That they said nothing is a bit alarming.